The Kaposin B protein of KSHV Activates the p38/MK2 Pathway and Stabilizes Cytokine mRNAs
The Kaposin B protein of KSHV Activates the p38/MK2 Pathway and Stabilizes Cytokine mRNAs
Science 2005 307:739-41
Speaker: 姚蕙雯
Commentator: 楊倍昌 教授
Time: 2005.03.30 14:00-15:00
Abstract:
Kaposi’s sarcoma-associated herpesvirus (KSHV), the etiological agent of Kaposi’s sarcoma and several lymphoproliferative diseases, is first identified as herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma at 19941. An important characteristic of KSHV-induced diseases is the high level of cytokine production2. However, the mechanism that contributes to the elevated cytokine production has not been identified. In this study, kaposin B protein, a product of the kaposin locus during latency, is found to interact with MAPK-associated protein kinase 2 (MK2), which contributes to the stabilization of mRNAs containing AU-rich elements (AREs)3, especially cytokine transcripts. While binding to kaposin B protein, MK2 is activated to abrogate ARE-mediated degradation of cytokine transcripts and subsequently promotes cytokine production. Although the actual mechanism that kaposin B protein expression leads to activation of MK2 is incomplete, it is proposed that binding of MK2 by kaposin B protein directly promotes MK2 activation, and the enhanced activity of p38 amplifies the initial effect. In addition, the augmentation of cytokine production in kaposin B-expressing cells might further stimulate p38/MK2 pathway through autocrine or paracrine loop. This study provides an explanation for elevated cytokine production in KSHV-associated diseases irrespective of the mechanistic details.
References:
1. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-9.
2. Komanduri, K. V., J. A. Luce, M. S. McGrath, B. G. Herndier, and V. L. Ng. 1996. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol 13:215-26.
3. Winzen, R., M. Kracht, B. Ritter, A. Wilhelm, C. Y. Chen, A. B. Shyu, M. Muller, M. Gaestel, K. Resch, and H. Holtmann. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. Embo J 18:4969-80.